Naglaa M. Kamal (M Yakoot, Mostafa Yakoot)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Binding Protein

Cross Sectional

Replacement Therapy

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of clinical research in pediatric endocrinology

Journal of medical virology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Naglaa M. Kamal
Nonsignificant trends in COVID-19 trials: Is there a significance? Journal of medical virology 94 (5) (2022)
Naglaa Fathy Barseem, Naglaa Fathy Barseem, Akram Elshafey Elsadek, Ashraf Hamed Al-shokary, Yehia Hamed Abdel Maksoud, Sameh Elsayed Abdulsamea, Iman M. Talaat, Hany Abdelaziz Suliman, Naglaa M. Kamal, Waleed E. Abdelghani, Sanaa Mohammed Azab, Dalia Mohamed Nour El Din
Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis Journal of clinical research in pediatric endocrinology 11 (4) (2019)
Enas M Kamal, Mortada El-Shabrawi, Hisham El-Khayat, Naglaa M. Kamal, Yehia Sameh, Yasser Fouad, Dina Attia
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
M H F El-Shabrawi, Naglaa M Kamal, H R El-Khayat, Enas M Kamal, M M A H AbdElgawad, Naglaa M. Kamal
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6- to 12- year old children. Alimentary pharmacology & therapeutics 47 (12) (2018)